Yu-hsuan Chang

Minato, 1088639, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.

Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.

Journal: International journal of hematology
Published: January 09, 2026

Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.

Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.

Journal: Biochemical and biophysical research communications
Published: November 14, 2025

Development of hematopoietic stem cell-targeted lipid nanoparticles through lipid composition optimization.

Development of hematopoietic stem cell-targeted lipid nanoparticles through lipid composition optimization.

Journal: Experimental hematology
Published: October 14, 2025

Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.

Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.

Journal: International journal of hematology
Published: October 04, 2025

BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

BCL11B enhancer hijacking by t(14;16)(q32;q24) translocation defines a novel high-risk subtype of T-ALL.

Journal: Blood
Published: September 03, 2025

Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance.

Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance.

Journal: Molecular cancer therapeutics
Published: August 18, 2025

The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis.

The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis.

Journal: Cancer science
Published: May 01, 2025

Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/p53 Co-Targeting Therapy Against AML.

Machine Learning-Based Predictive Modeling Maximizes the Efficacy of mTOR/p53 Co-Targeting Therapy Against AML.

Journal: Cancer science
Published: April 18, 2025

Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity.

Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity.

Journal: Nature cardiovascular research
Published: May 03, 2024

HDAC7 is a potential therapeutic target in acute erythroid leukemia.

HDAC7 is a potential therapeutic target in acute erythroid leukemia.

Journal: Leukemia
Published: March 12, 2024

SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation.

SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation.

Journal: Cell reports
Published: November 17, 2023

CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.

CHIP-associated mutant ASXL1 in blood cells promotes solid tumor progression.

Journal: Cancer science
Published: December 07, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026